Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities is a REIT focused on life science and technology campuses, with a strong evidentiary signal from concentrated congressional trading and executive branch holdings, including a $100K-$250K purchase by a member in March 2026 and a holding by former President Trump.
BusinessWhat ARE does
Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT) that owns, operates, and develops collaborative life science and technology campuses in key urban innovation clusters. Its revenue is derived primarily from leasing laboratory and office space to pharmaceutical, biotechnology, and technology tenants. The company's business model is centered on providing specialized infrastructure to the healthcare and technology sectors.
12 months past · 3 months futureARE activity timeline
Executive Branch ConflictsARE held by Trump-administration officials
Lifetime Government AwardsARE federal contracts
ARE doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding ARE
Politicians Trading AREMembers of Congress with recent ARE positions
Congressional TradesWho in Congress is trading ARE
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Open-market buys
Stock awards & option exercises
Bills Affecting ARELive legislation impacting this stock
Political ProfileWhere ARE sits in Washington
[object Object]
STRUCTURAL: Exposure to healthcare sector regulation via 8 pending bills with material revenue impacts. EVIDENTIARY: Concentrated, high-value congressional trading by Rep. Mullin (8 buys, 1 sale in 12 months) and a holding by former President Trump (`get_executive_branch_exposure.by_ticker[0].holdings`). Net: Strong evidentiary signals from political actors trading/holding the stock outweigh the absence of structural lobbying influence.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Broad legislative impact from multiple healthcare billsU.S. Congress"`Recent bill_impacts` lists 8 healthcare bills with material estimated revenue impacts, ranging from $9.75M to $14.25M."
Regulatory opportunities
- No specific regulatory opportunities flagged.
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Live signals + predictions for ARE — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades ARE
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord